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graphic (CT) analysis. This provides a report compara-
ble with that presented by Gaudino and associates.1
Methods
A study was designed in 1992 to compare 3 perfusion tem-
peratures, cold (20°C), tepid (32°C), and warm (37°C), for
CPB during coronary revascularization in a prospective ran-
domized manner to study the neurologic sequelae of
hypothermic versus normothermic perfusion. The patients in
this study had either elective or urgent operations and required
3 or more grafts, thus ensuring at least a 60-minute CPB time.
As in the Gaudino publication,1 these patients were all in a
“low risk category” for neurologic injury, limiting age to less
than 76 years and having no prior neurologic history. Other
exclusion criteria were poor left ventricular function (ejection
fraction < 30%), ongoing myocardial ischemia necessitating
an intra-aortic balloon, renal dysfunction with a serum creati-
nine level more than 2.0 mg/L, or recent (<7 days) postinfarc-
tion angina and carotid stenosis of more than 70% by duplex
scan. Randomization took place in the operating room imme-
diately before the operation by choosing the temperature from
a sealed envelope. The study was approved March 4, 1993, by
the Institutional Review Board of Baystate Medical Center. 
The first patient was enrolled on February 7, 1994, and the
trial was completed on December 4, 1997, a study period just
T he impetus for this report is an article from CatholicUniversity in Rome describing the increased severi-
ty of intraoperative cerebral injury associated with nor-
mothermic cardiopulmonary bypass (CPB).1 Our group
recently completed a National Institutes of Health trial
of normothermic versus hypothermic perfusion for
coronary revascularization, and we duplicated the
approach used in the aforementioned study to measure
the volume of infarct size based on computed tomo-
Objective: This study was designed to compare the volume of cerebral
infarction in patients operated on under either hypothermic or
tepid/normothermic perfusion for coronary revascularization. Methods:
A randomized trial with preoperative, postoperative, and late neurolog-
ic evaluation was conducted in patients undergoing coronary revascu-
larization having either hypothermic or tepid/normothermic perfusion
for coronary revascularization. The goal was to determine whether per-
fusion temperature correlated with neurologic dysfunction associated
with coronary artery bypass. Results: Twelve intraoperative ischemic
strokes occurred during coronary revascularization in a series of 291
patients. Six of these were in the group receiving hypothermic perfusion
and 6 in groups receiving the tepid/normothermic perfusion. Measuring
the infarct volume documented that 3 of the strokes in each group
resulted in minor or small infarcts and 3 in each group were significant,
major strokes. The volume of infarction, whether including all 6 patients
in each group or only those with major strokes, was no different between
the hypothermic and the tepid/normothermic groups. Conclusions: In
this series of 291 patients randomized to perfusion temperature, we
observed no relationship between the size of a cerebral ischemic infarct
and the perfusate temperature during coronary revascularization.
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short of 4 years. A total of 291 patients were enrolled. A
detailed neurologic evaluation was performed before the
operation, 3 to 4 days after the operation (before discharge),
and at 1 month when returning for a postoperative visit.
Whenever the neurologist detected an abnormality suggestive
of a stroke, a cerebral CT scan was performed. This was
accomplished in 49 patients.
The intent of this study was to see whether any relationship
exists between the perfusion temperature and the size of an
intraoperative cerebral infarction. The method for measuring
the volume of infarct is the same as that used in the Gaudino
paper,1 which was validated in 2 prior publications by
Petersen and associates.2,3 This approach entails measuring
the width and length of the lesion on the axial CT slice, mul-
tiplying the 2 measurements, and then multiplying the result
by the thickness of the CT slice (10 mm). When lesions
appeared on multiple views, the volume of each was added to
obtain the total volume of infarction.
Method of anesthesia. Anesthesia was used in a consistent
manner across all temperature groups: premedication with
lorazepam (1-2 mg orally); induction with fentanyl (5-15
µg/kg intravenously), midazolam (0.05 mg/kg intravenously),
and pancuronium (0.15 mg/kg intravenously); and mainte-
nance with fentanyl (<10 µg/kg intravenously), and isoflu-
rane titrated as tolerated (usually 0.5%-1.0%). The patient
was extubated as expeditiously as possible consistent with
patient safety. Although no medication was given after the
operation to maintain paralysis, no patients had reversal of
pancuronium. In patients who were hypothermic and shiver-
ing after the operation, medication was administered to facil-
itate a comfortable recovery. Fast-track extubation and recov-
ery were attempted in every patient.4
Method of CPB. A Cobe roller pump (Cobe Cardio-
vascular Inc, Arvada, Colo) and the Affinity hollow-fiber
membrane oxygenator (Avecor Cardiovascular Inc, Plymouth,
Minn) were used for CPB. Heparin bonding was not used in
the perfusion tubing or oxygenator. An 8-mm Sarns aortic
arch cannula (Sarns/3M Health Care, Ann Arbor, Mich) or a
20F DLP arterial cannula (DLP Inc, Grand Rapids, Mich)
was used for aortic cannulation and a 36F dual-drainage sin-
gle venous catheter from Research Medical (Midvale, Utah)
was used for venous return. A DLP Gundry RCSP 15F coro-
nary sinus catheter was used for retrograde cardioplegia. The
volume of CPB perfusate was 2 L · min–1 m–2 body surface
area or more in patients receiving 20°C perfusion and near 3
L · min–1 m–2 body surface area for patients receiving 32°C or
37°C perfusion. Venous saturation was maintained at more
than 70%, and mean perfusion pressure was regulated to 60
to 80 mm Hg by use of phenylephrine for vasoconstriction
and isoflurane for vasodilation. The hematocrit value was
maintained at 20% or more during perfusion and at 22% or
more during recovery. Activated clotting times and heparin
levels were monitored before CPB and every 30 minutes dur-
ing CPB. The initial heparin dose was 500 U/kg, given intra-
venously, and additional heparin was given if the activated
clotting time was less than 600 seconds or the heparin level
was less than 3 mg/kg. The pH regulation throughout the
operation was maintained by alpha-stat management.
Antifibrinolytic agents, including aminocaproic acid
(Amicar) and aprotinin, were not administered in this study.
The perfusate temperature used in this study was the only
difference among the 3 groups. In the normothermic group,
perfusate temperature was maintained at 37°C and no higher.
In the hypothermic group (20°C), we deliberately decreased
the temperature to the chosen level gradually so that a 10°C
maximal difference existed between arterial and venous
blood. Core temperature reached 35°C to 36°C in the nor-
mothermic group, 32°C to 33°C in the tepid group, and 23°C
to 28°C in the hypothermic group. Cooling, when indicated,
began soon after commencement of CPB and continued until
arterial perfusate temperature reached either 32°C (soon after
commencing cooling) or 20°C (often taking 15-30 minutes).
Crossclamp application and coronary artery bypass grafting
were performed immediately on initiation of CPB.
Rewarming began with initiation of the last distal anastomo-
sis, usually the left internal thoracic artery to the left anterior
descending coronary artery. Again, rewarming was slow with
maintenance of a 10°C maximal gradient between arterial
and venous blood. Rewarming never exceeded a perfusate
temperature of 39°C until 1996 and 38oC from 1996 to 1998.
Operative technique. Antegrade-retrograde blood cardio-
plegia was used with administration into the coronary sinus
and each completed vein graft for 3 of the 4 surgeons
(R.M.E., J.A.R., and D.W.D.). Proximal anastomoses were
performed with a side-biting clamp after unclamping. The
fourth surgeon used a single crossclamp for both anasto-
moses, using then only retrograde cardioplegia.
Statistical analysis. The Fisher exact test was used to
determine significant differences in the rate of occurrence of
ischemic stroke between patient groups defined by perfusate
temperature. To make the study comparable with that pre-
sented by Gaudino and associates,1 in which normothermic
perfusion was defined as 34°C to 37°C, we combined the
tepid (32°C) and normothermic (37°C) groups from our study
and considered them normothermic for these analyses. A 2-
sample t test was used to compare the estimated ischemic
cerebral infarct volume for the 2 groups of patients, nor-
mothermic or hypothermic (20°C). Because of the small sam-
ple size and large spread of the data, a Mann-Whitney 2-sam-
ple rank sum test was also performed. Data are reported for
each group as the infarct size, median, and range of values.
Results
Forty-nine patients of the 291 in the trial had the sus-
picion of a cerebral vascular accident (CVA) (16.8%),
and a CT scan was performed. Thirteen or 4.5% of the
291 had a documented CVA by CT scan, 4 who
received warm perfusion, 3 tepid perfusion, and 6 cold
perfusion. One of the patients receiving warm perfu-
sion had a CVA related to atrial fibrillation immediate-
ly before discharge from the hospital. Although he is
included as having had a CVA in the trial, it was clear-
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ly not an intraoperative event. The remaining 12
patients comprised the study group, 6 considered nor-
mothermic and 6 hypothermic.
The actual computation of infarct volume was useful
since it allowed an objective measure of stroke severity.
In the hypothermic patients, 3 had significant infarcts,
defined as more than 300 mm3, and similarly in the nor-
mothermic series, 3 were significant. The absence of a
significant infarct was associated with minimal deterio-
ration in neurologic function and, in fact, no infarction
was apparent to the patient and his or her family. Only
a sophisticated neurologic evaluation uncovered an
ischemic CVA. Nonsevere strokes were most often
associated with lacunar or watershed infarctions. 
Quantification of infarct size resulted in the follow-
ing data: for the normothermic group, volumes ranged
from 60 to 5630 mm3, with a median of 900 mm3. For
the hypothermic group, the median was 720 mm3, with
volumes ranging from 130 to 5890 mm3. If one elimi-
nates the minor strokes from this analysis (3 patients
from each group), then the infarct volumes are clearly
larger for both groups, but there is still no significant
difference in infarct volumes between the 2 tempera-
ture groups. With severe ischemic insults alone, the 2
groups remain comparable: infarct volumes of 1520,
3260, and 5630 mm3 were observed in the normother-
mic group and volumes of 1260, 4390, and 5890 mm3
in the hypothermic group. 
Discussion
Substantial data exist to support the proposition that
hyperthermia in the presence of acute stroke, even of a
small degree, such as elevations between 37.5°C and
38°C, is deleterious to central nervous system (CNS)
function, leading to an increase in infarct size.5 Indeed,
a recent report documented improved neurologic func-
tion in the setting of acute traumatic brain injury asso-
ciated with therapeutic hypothermia.6 Thus the concept
of reducing CNS infarct size during CPB by using
hypothermia has inherent appeal.
The issues, however, are by no means clear-cut.
When patients are hypothermic, they must be
rewarmed to discontinue CPB, and this rewarming
process may lead to cerebral hyperthermia.7 Addition-
ally, the development of cerebral embolization is most
often associated with periods when the brain is warm,
such as on initiation of CPB (blast effect of blood flow)
and crossclamp application and removal.8 Thus the use
of deliberate hypothermia may not be advantageous but
rather lead to a situation in which hyperthermia is
inevitable, a consequence of the process of rewarming. 
Our study was a randomized trial and for this reason
holds a potential advantage over that of Gaudino and
associates,1 which was a sequential analysis with the
hypothermic group treated first. Our study found 12
intraoperative strokes among 291 patients whereas
their analysis found 25 of 2987. However, our analysis
used a sophisticated neurologic evaluation in all 291
patients, and in their study the anesthesiologist evaluat-
ed the presence of a CNS event. Thus 6 of the 12 CVAs
in our analysis would have gone undetected because
they were associated with no apparent CNS deficit in
the opinion of both the attending surgeon and the
patient. These were associated with small infarcts
(<300 mm3) usually in the watershed or lacunar region.
The implications of the Gaudino report1 are certainly
worthy of consideration, but the variability of patients
and their clinical setting is such as to prevent a conclu-
sion that normothermic perfusion is detrimental.
Rather, one could conclude that maintenance of a per-
fusion temperature at 34°C to 37°C is most important
during CPB. In fact, this is best accomplished if
hypothermia is avoided completely, allowing rewarm-
ing to be accomplished without aggressive elevation of
perfusion temperature.
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